Anthony Sinskey
Founder at YIELD10 BIOSCIENCE, INC.
Net worth: 15 361 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gary Crocker | M | 72 | 20 years | |
Simon Williams | M | - |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA.
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | 32 years |
Oliver Peoples | M | 66 | 32 years | |
Lynne Brum | F | 60 | 13 years | |
Ulrik Nielsen | M | 52 | 31 years | |
Robert van Nostrand | M | 67 |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | 18 years |
Charles Haaser | M | 68 | 16 years | |
Richard Hamilton | M | 61 | 7 years | |
Willie Loh | M | 69 | 2 years | |
Greg Lee | M | 77 |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Scott Pickering | M | - |
ABEC, Inc.
ABEC, Inc. Engineering & ConstructionIndustrial Services ABEC, Inc. is a private company that provides engineered process solutions and services for manufacturing in the biotech industry. ABEC is based in Bethlehem, PA and has subsidiaries in Ireland. The majority of the world's pharmaceutical and biotech companies are ABEC customers, with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. The company was founded in 1974 by Jack Wilson, and the CEO is Scott Pickering. | - |
Sherri Brown | M | 63 | 4 years | |
Matthew Fetherman | M | - |
ABEC, Inc.
ABEC, Inc. Engineering & ConstructionIndustrial Services ABEC, Inc. is a private company that provides engineered process solutions and services for manufacturing in the biotech industry. ABEC is based in Bethlehem, PA and has subsidiaries in Ireland. The majority of the world's pharmaceutical and biotech companies are ABEC customers, with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. The company was founded in 1974 by Jack Wilson, and the CEO is Scott Pickering. | - |
Ana Arakelian | F | - | - | |
John Zhang | M | - | - | |
Gigi Hirsch | M | - |
MIT Center for Biomedical Innovation
MIT Center for Biomedical Innovation Miscellaneous Commercial ServicesCommercial Services MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA. | - |
Kristin Neubauer | F | - | - | |
Lucas Wenthe | M | - | 6 years | |
Luca Giannone | M | - | - | |
Sally Aaron | F | - | - | |
Jeremy Klaperman | M | - | - | |
Kristi Snell | M | 56 | 27 years | |
Steven Chen | M | 59 | 10 years | |
Robert Goforth | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Jerome Meier | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Kevin Ohashi | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
David P. Martin | M | - |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | 26 years |
Said Rizik | M | - |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | 21 years |
Scott Roth | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Charles Hartnett | M | - |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | - |
Richard B. Emmitt | M | 79 |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | - |
G. Steven Burrill | M | 79 |
MIT Center for Biomedical Innovation
MIT Center for Biomedical Innovation Miscellaneous Commercial ServicesCommercial Services MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA. | - |
Hadi Omrani | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joseph H. Shaulson | M | 58 | 7 years | |
Matthew Strobeck | M | 51 |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | 11 years |
Jay Kouba | M | 71 | 8 years | |
Johan van Walsem | M | 61 | 15 years | |
Richard P. Eno | M | 63 | 6 years | |
Andrew Joiner | M | 62 |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | - |
Robert J. Mulroy | M | 59 | 17 years | |
James Barber | M | 70 |
Massachusetts Institute of Technology
| 11 years |
Gary E. Frashier | M | 86 |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | 3 years |
William A. Sullivan | M | 52 | 10 years | |
Joseph D. Hill | M | 61 | 6 years | |
Jeffrey A. Munsie | M | 47 | 8 years | |
Scott A. Miller | M | - |
Massachusetts Institute of Technology
| 6 years |
Catherine Corrigan | M | 55 |
Massachusetts Institute of Technology
| 5 years |
Ted Tomlinson | M | - |
Massachusetts Institute of Technology
| 5 years |
James Quigley | M | 71 | 7 years | |
Beth A. Marcus | M | - |
Massachusetts Institute of Technology
| 5 years |
Barbara H. Wells | M | 68 | 3 years | |
Javier de Luis | M | - |
Massachusetts Institute of Technology
| 8 years |
Ilya Lisansky | M | - |
Massachusetts Institute of Technology
| 4 years |
Jamie Flinchbaugh | M | - |
Massachusetts Institute of Technology
| 2 years |
Morten Aleksandr Engel | M | - |
Massachusetts Institute of Technology
| 5 years |
Mostafa Terrab | M | 68 |
Massachusetts Institute of Technology
| 5 years |
David Miller | M | - |
Massachusetts Institute of Technology
| 21 years |
Tom A. Stefanick | M | - |
Massachusetts Institute of Technology
| 5 years |
Guo Zhong Xie | M | 64 |
Massachusetts Institute of Technology
| 4 years |
Vivian Lee | M | 57 | 4 years | |
Morris Kesler | M | - |
Massachusetts Institute of Technology
| 5 years |
Huan Liu | M | - |
Massachusetts Institute of Technology
| 5 years |
William McClements | M | 60 | 6 years | |
Gavin MacBeath | M | 54 | 24 years | |
Harry Atwater | M | - |
Massachusetts Institute of Technology
| 10 years |
J. P. Michael Motion | M | - |
Massachusetts Institute of Technology
| 6 years |
Stephanie Thomas | F | - |
Massachusetts Institute of Technology
| 6 years |
Louis S. Metzger | M | - |
Massachusetts Institute of Technology
| 10 years |
K. Michael Forrest | M | 80 |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | 3 years |
Edward M. Muller | M | 88 | - | |
Edward Giles | M | 87 | 19 years | |
Michael Porter | M | 76 | 8 years | |
Walter M. Lovenberg | M | 89 | 12 years | |
Stephen J. Large | M | 66 | 1 years | |
Celeste Mastin | F | 55 | 5 years | |
Sarah P. Cecil | F | 72 | - | |
Jonathan Shane | M | - |
Massachusetts Institute of Technology
| 6 years |
William Feehery | M | 54 |
Massachusetts Institute of Technology
| 5 years |
John Mendelsohn | M | 87 | 5 years | |
Ethan E. Jacks | M | 70 |
Massachusetts Institute of Technology
| 5 years |
Russ Ray | M | 77 | 7 years | |
Peter Kellogg | M | 67 | 13 years | |
Gordon J. Fehr | M | 90 | 16 years | |
Andy Fillat | M | - |
Massachusetts Institute of Technology
| 5 years |
Sarah Nash | F | 70 | 8 years | |
Brian Daniels | M | 65 |
Massachusetts Institute of Technology
| 4 years |
Mark A. Clements | M | - |
Massachusetts Institute of Technology
| 3 years |
James van B. Dresser | M | 82 | 15 years | |
Brian L. Hamilton | M | 76 | 2 years | |
Benjamin van Roy | M | - |
Massachusetts Institute of Technology
| 8 years |
Carlo Tursi | M | 41 |
Massachusetts Institute of Technology
| 9 years |
Bert Richards | M | - |
Massachusetts Institute of Technology
| 5 years |
George Economou | M | 71 |
Massachusetts Institute of Technology
| 5 years |
Abhay Parekh | M | - |
Massachusetts Institute of Technology
| 5 years |
Timothy L. Gasperoni | M | - |
Massachusetts Institute of Technology
| 2 years |
Gary A. Merriman | M | 69 |
Massachusetts Institute of Technology
| 1 years |
Emanuel M. Sachs | M | - |
Massachusetts Institute of Technology
| 3 years |
Kevin Stuart Peskin | M | - |
Massachusetts Institute of Technology
| 2 years |
Patrizia Canziani | M | - |
Massachusetts Institute of Technology
| 4 years |
Faizal Javer | M | - |
Massachusetts Institute of Technology
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anthony Sinskey
- Personal Network